Published in J Soc Gynecol Investig on July 12, 2002
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer (2004) 1.84
Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett (2006) 1.03
Sexual dimorphism in immune response genes as a function of puberty. BMC Immunol (2006) 0.98
Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes. Endocrinology (2005) 0.91
Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control (2008) 0.88
Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol (2005) 0.76
Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res (2008) 6.47
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics (2003) 3.78
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle (2009) 3.60
A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science (2008) 3.52
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A (2005) 3.22
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res (2006) 3.21
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A (2007) 2.22
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res (2010) 2.15
Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells (2009) 1.84
Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest (2008) 1.82
A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology (2004) 1.76
Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol (2003) 1.65
Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol (2007) 1.65
Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells. Oncogene (2003) 1.65
Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol (2004) 1.64
Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res (2003) 1.52
Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol (2004) 1.51
Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol (2004) 1.49
7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells. Cancer Biol Ther (2009) 1.48
Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril (2010) 1.46
Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol (2013) 1.45
Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype. J Soc Gynecol Investig (2004) 1.42
Inflammation and implantation. Am J Reprod Immunol (2010) 1.41
Toll-like receptor-mediated responses by placental Hofbauer cells (HBCs): a potential pro-inflammatory role for fetal M2 macrophages. Am J Reprod Immunol (2014) 1.40
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci U S A (2002) 1.40
Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol (2010) 1.39
The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev (2005) 1.37
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol (2002) 1.29
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc Natl Acad Sci U S A (2011) 1.29
Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol (2009) 1.29
Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther (2011) 1.28
Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer (2006) 1.27
A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol (2005) 1.27
Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol (2005) 1.26
First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod (2004) 1.25
Placental apoptosis in health and disease. Am J Reprod Immunol (2010) 1.25
Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol (2010) 1.25
Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol (2003) 1.22
Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol (2010) 1.21
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. J Transl Med (2007) 1.21
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin Cancer Res (2004) 1.20
A novel three-dimensional in vitro system to study trophoblast-endothelium cell interactions. Am J Reprod Immunol (2007) 1.20
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol (2009) 1.20
Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res (2004) 1.20
Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17
Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol (2011) 1.15
Biological significance of prolactin in gynecologic cancers. Cancer Res (2009) 1.13
TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence. Cell Cycle (2013) 1.12
Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway. Cell Cycle (2011) 1.11
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. J Clin Oncol (2007) 1.10
Macrophage migration inhibitory factor expression in ovarian cancer. Am J Obstet Gynecol (2007) 1.09
Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C). Hum Reprod (2006) 1.09
Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci (2008) 1.08
Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients. J Soc Gynecol Investig (2004) 1.08
NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. Cancer (2009) 1.07
Sexual function is related to body image perception in women with pelvic organ prolapse. J Sex Med (2009) 1.07
Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol (2011) 1.07
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model. Lab Invest (2004) 1.05
Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol (2014) 1.03
Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer (2011) 1.03
Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett (2002) 1.03
TLR6 modulates first trimester trophoblast responses to peptidoglycan. J Immunol (2008) 1.03
Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. Int J Surg Pathol (2004) 1.02
X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod (2004) 1.02
Toll-like receptors and pregnancy: trophoblast as modulators of the immune response. J Obstet Gynaecol Res (2009) 1.02
Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs. Expert Opin Pharmacother (2009) 1.00
XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway. J Biol Chem (2007) 1.00
Viral infection of the pregnant cervix predisposes to ascending bacterial infection. J Immunol (2013) 0.99
Cesarean scar ectopic pregnancy: case series and review of the literature. Am J Perinatol (2009) 0.99
Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells. Am J Reprod Immunol (2010) 0.99
Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod (2002) 0.98
Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype. Am J Reprod Immunol (2011) 0.98
Obstruction of the superior vena cava cannula detected by desaturation of the cerebral oximeter. J Cardiothorac Vasc Anesth (2005) 0.97
Isolation of hofbauer cells from human term placentas with high yield and purity. Am J Reprod Immunol (2011) 0.97
In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer. Breast Cancer Res Treat (2005) 0.95
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment. Cancer Med (2013) 0.95
Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers. Int J Gynecol Cancer (2011) 0.94
Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. J Matern Fetal Neonatal Med (2012) 0.94
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer. Yale J Biol Med (2006) 0.93
The role of Fas mediated apoptosis in preeclampsia. J Perinat Med (2005) 0.92
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer (2010) 0.92
Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. RNA (2008) 0.92
Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol (2011) 0.92
Alterations in syncytiotrophoblast cytokine expression following treatment with lipopolysaccharide. Am J Reprod Immunol (2006) 0.91